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Abstract
Background The aim of the study was to evaluate the
quality of life (QoL) in patients affected by osteoarthritis
(OA) secondary to congenital hip dysplasia (CHD) and
treated by hip arthroplasty.
Methods We prospectively treated 40 patients admitted to
our hospital between 2001 and 2006. Each patient was
asked to answer to two questionnaires: WOMAC and MOS
SF-36. Patients were evaluated four months before surgery
and once they had achieved postoperative rehabilitation.
Pre- and postoperative results were analyzed and compared
with the international literature on patients affected by OA
and also with a healthy population.
Results Pre- and post-operative results: WOMAC: pain
14.06–0.84; stiffness 4.26–0.52; function 42.68–5.39. SF-
36: physical function 18.55–84.52; role physical 28.33–
87.10; body pain 23.26–83.39; general health 55.19–81.74;
vitality 32.74–72.10; social function 43.55–84.66; role
emotional 68.82–93.55; mental health 48.77–79.35. All
results were statistically signiﬁcant.
Conclusions The study reports an important QoL
improvement in patients affected by arthritis secondary to
CHD that underwent hip surgery, and underlines differ-
ences with respect to primary OA. QoL evaluation cannot
replace either clinical and instrumental evaluation or the
physician’s experience, but it can give weight to the
patient’s expectations, and may be considered an efﬁcient
test for medical and surgical treatments.
Keywords Hip  Arthritis  Total hip replacement 
Congenital hip dysplasia
Introduction
Quality of life (QoL) has been deﬁned by the World Health
Organization (WHO) as a ‘‘multidimensional’’ model
which includes physical, material, social and emotional
wellbeing, as well as individual development and daily
activity [1]. The complexity of this concept makes it
challenging to create validated instrumentation for the
evaluation of QoL after treatment.
Clinical and functional characteristics of patients treated
with total hip replacement (THR) for congenital hip dys-
plasia (CHD) differ from those treated for primary hip
osteoarthritis (OA), in part due to the lower mean age of
those affected by CHD. The primary aim of this study was
to assess quality of life after total hip replacement in
patients with CHD, using one general and one speciﬁc
validated QoL indicator. We compare our results to the
published literature on QoL in OA patients, and assess the
relative validity of these instruments in the CHD
population.
Materials and methods
Study approval was obtained from the ethical committee of
our institution, in full compliance with the Declaration of
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this study prior to case review.
Between June 2001 and January 2006, we identiﬁed
patients who underwent total hip arthroplasties (THA)
performed by the senior author. The inclusion criterion was
diagnosis of OA secondary to CHD (Crowe’s classiﬁcation
type I or II). The exclusion criterion was revision hip
surgery.
Each patient was asked to answer two questionnaires
by phone, the Short-Form 36 (SF-36) and the Western
Ontario and MacMaster University Osteoarthritis Index
(WOMAC). The SF-36 is a generic measure of QoL with
36 questions. It consists of an eight-scale proﬁle of func-
tional health and well-being, as well as psychometrically
based physical and mental health summary measures. The
SF-36 is often used as point of reference for other tests
[2, 3]. Final score is proportional to individual well-being
[4, 5]. The WOMAC is a validated instrument designed
speciﬁcally for the assessment of lower extremity pain and
function. Usually self-administered, the WOMAC assesses
pain, disability and joint stiffness in knee and hip osteo-
arthritis using a battery of 24 questions. It is useful for the
clinical evaluation of disease treatment, speciﬁcally for
short-term investigations [6–8]. Final score is proportional
to individual disability.
The questionnaires were adminstered pre-operatively,
and at a minimum of four months after rehabilitation was
completed. The questionnaires were scored per their
respective operating manuals [9, 10]. All results were
compared with the published literature, and SF-36 results
were also compared with those of healthy Italian popula-
tions aged 45–54 years, corresponding to the study
cohort’s mean age [4, 5, 8, 11, 13–18].
The standard deviation (SD) and effect size (a measure
of the strength of the difference between two groups) was
calculated for each survey item pre- and post-operatively
[11]. Each item was also analyzed for normality
(Kolmogorov–Smirnov test). The Student t-test was used
for paired comparisons when the data was normally
distributed, and the Wilcoxon signed-ranks test for non-
parametric data. Signiﬁcance was set at 0.05. Data analysis
was carried out using SPSS (Chicago, IL, USA).
Results
We identiﬁed 40 THAs in 40 consecutive patients per-
formed by a single surgeon. Four patients were unavailable
for survey completion. Three patients were excluded due to
revision surgery, and two patients were excluded as they
had not yet completed their rehabilitation. The study group
was thus composed of 31 patients. There were 28 females
and 3 males, with a mean age at surgery of 51 years (range
33–70). The mean follow-up time was 36 months (range 4–
60). There were 13 patients with a Type I Crowe classiﬁ-
cation, and 18 patients with a type II classiﬁcation. All
cases utilized a Conus-type stem and a Fitmore-type cup
(Zimmer GmbH, Winterthur, Switzerland).
Results from the SF-36 are collated in Table 1. Effect
sizes of of 0.2, 0.5 and 0.8 indicate small, medium and
large differences, respectively. The effect size (ES) for
physical functioning was ES = 3.72, ES for bodily pain
= 2.45, and ES for role emotional = 0.61.
The percentage relative increase ranged from 36 to
356%. All values were statistically signiﬁcant for
P\0.05.
Results from the WOMAC are collated in Table 2.A sa
reminder, the ﬁnal score is proportional to individual dis-
ability, i.e., a patient with less pain/disability should have a
lower score. Once again, the ES and percentage relative
increase demonstrated statistically signiﬁcant improve-
ments between the patients’ pre- and post-operative values.
Discussion
In this study, 100% of all questionnaire items were
obtained, which should be compared with the literature,
Table 1 SF-36 results
Scale Pre-operative
mean value (SD)
Post-operative
mean value (SD)
P value Effect size % Relative
increase
Physical functioning 18.55 (17.71) 84.52 (12.67) 0.000 3.72 355.47
Role physical 28.33 (41.20) 87.10 (24.89) 0.000 1.43 207.45
Bodily pain 23.26 (24.59) 83.39 (19.67) 0.000 2.45 258.51
General health 55.19 (23.26) 81.74 (15.39) 0.000 1.14 48.11
Vitality 32.74 (28.78) 72.10 (17.78) 0.000 1.37 120.22
Social functioning 43.55 (29.73) 84.66 (18.17) 0.000 1.38 94.40
Role emotional 68.82 (40.31) 93.55 (20.04) 0.011 0.61 35.93
Mental health 48.77 (32.26) 79.35 (14.68) 0.000 0.95 62.70
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or multiple [12].
Patients in the THA literature generally have primary
osteoarthritis [11, 13, 14]. Osteoarthritis secondary to CHD
usually represents only 2–3% of all diagnoses [11, 14]. With
respect to the SF-36 survey, our results were equivalent or
better than studies where primary OA was the principal
diagnosis (with higher patient mean ages) (Fig. 1).
Published role-physical preoperative values range from
19.5 to 27.05, and post-operative values from 52.41 to
66.6, while these values ranged from 18.55 to 84.52 in our
patient cohort [11, 13, 14]. We noticed the same tendency
for the bodily pain scale, with preoperative values ranging
from 27.1 to 32.90 and post-operative values from 58.79 to
72.8 in the literature, versus a range of 23.26–83.39 in our
study [11, 13, 14]. General health and vitality pre-operative
values in our study were mainly lower than in the literature,
and post-operative values were higher [11, 13, 14]. Role-
emotional values were higher both pre- and post-opera-
tively in our study [11, 13].
A lower mean age, with a resultant lower comorbidity
disease burden, may explain why our patient cohort
achieved higher ﬁnal post-operative clinical SF-36 results
than primary OA patients from the literature [19]. Patients
in our cohort had lower pre-operative mental health scores
than the published literature: younger patients may be less
able to cope with functional limitations than their older
peers. Post-operative scores were similar (79.4 vs. 79.4).
This reasoning may equally apply to social functioning as
well.
Interestingly, our patient cohort displayed better post-
operative results on the SF-36 than healthy controls aged
45–54 years, except for the role-physical scale (Fig. 2).
This could have been due to a recall bias: recently reha-
bilitated patients may have tended to overvalue their
current physical condition when making a pre-operative
comparison (when the clinical and psychological effects of
their condition were presumably at their worst).
Comparison of our patients with the literature using the
WOMAC was complicated by the diverse methods used to
report results (raw score, percentage, visual analog scale)
[8, 15–18]. We generally observed a greater score decrease
(meaning improvement in QoL) among our cohort (Fig. 3).
This was probably due to the relatively lower mean patient
age (51 vs. 65–68 years), and to clinical differences
between CHD and primary OA [11, 13].
Considering that CHD essentially affects young women,
social functioning and mental health evaluation is critical:
it has been observed that females aged\65 years who are
affected by chronic disease suffer more frequently from
psychological disorders than men [14].
Our results indicate that both the SF-36 and WOMAC
are valid and complementary evaluation instruments. The
WOMAC assesses physical outcomes, while the SF-36 is
Table 2 WOMAC results Scale Pre-operative
mean value (SD)
Post-operative
mean value (SD)
P value Effect size % Relative
increase
Pain 14.06 (5.05) 0.84 (1.83) 0.000 2.62 1,573.80
Stiffness 4.26 (2.62) 0.52 (0.99) 0.000 1.43 719.23
Function 42.68 (12.83) 5.39 (5.70) 0.000 2.91 691.84
Global 61 (17.35) 6.74 (7.41) 0.000 3.13 805.04
Fig. 1 SF-36 pre and post-operative results in CHD and primary hip
OA [11, 13, 14]
Fig. 2 SF-36 pre- and post-operative results in CHD and healthy
populations in the 45–54-year-old age group [4, 5]
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[21]. Utilization of these QoL indicators alongside more
traditional evaluation instruments, such as the Harris hip
score, continues to increase in the literature [14, 20].
Orthopedic surgeons may wish to address clinical
decision-making from not only physical and radiologic
ﬁndings but also the context of QoL: the timing of an
operation can, for example, be delayed until any attendant
psychological or social concerns are addressed. That being
said, quality of life evaluations should neither replace
clinical and radiographic examination nor be used inde-
pendently as the basis for a surgical indication [19].
Quality of life evaluation may help with the qualitative
determination of the patient’s motivations and expectations
for joint replacement. QoL questionnaires can also be used
for patient follow-up and satisfaction, either alone or in
concert with other surveys [7, 8, 22–24].
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